Inventor
ELLA IOFFE
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes12%
A01KAnimal husbandry8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
12,389,889Mouse having a humanized cluster of differentiation 47 gene202512,187,772IL10 agonists and methods of use thereof202512,024,570Anti-CTLA-4 antibodies and uses thereof202411,910,788Mouse having a humanized cluster of differentiation 47 gene202411,692,032Anti-LAG3 antibodies and uses thereof202311,673,930IL10 agonists and methods of use thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to REGENERON PHARMA (6)· patent assignee history
2023Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 6 | 2023–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2023–2025 |